Difficulty: Medium
Average Score: 88%
Practice
Poor prognostic factors in Hodgkin lymphoma include all the following EXCEPT
Correct answer
A
Rationale
In Hodgkin lymphoma, poor prognostic factors are important to consider for treatment planning and patient outcomes. The correct answer is A) age of more than 15 years at the time of diagnosis. This is because pediatric patients with Hodgkin lymphoma generally have a better prognosis compared to older individuals. Younger age is associated with a more favorable response to treatment and overall survival.
Option B) stage IV disease is a poor prognostic factor because it indicates widespread disease dissemination, making treatment more challenging and outcomes less favorable. Option C) manifested by PET scan positivity is also a poor prognostic factor as it suggests more aggressive disease behavior and resistance to treatment. Option D) poor response to therapy is an obvious poor prognostic factor as it indicates that the disease is not being controlled effectively.
Educationally, understanding poor prognostic factors in Hodgkin lymphoma is crucial for healthcare providers involved in the care of pediatric patients with this condition. By recognizing these factors, clinicians can tailor treatment plans to optimize outcomes and provide appropriate support to patients and their families. It is essential to consider both clinical and biological factors when assessing prognosis in Hodgkin lymphoma to ensure the best possible care for patients.
Option B) stage IV disease is a poor prognostic factor because it indicates widespread disease dissemination, making treatment more challenging and outcomes less favorable. Option C) manifested by PET scan positivity is also a poor prognostic factor as it suggests more aggressive disease behavior and resistance to treatment. Option D) poor response to therapy is an obvious poor prognostic factor as it indicates that the disease is not being controlled effectively.
Educationally, understanding poor prognostic factors in Hodgkin lymphoma is crucial for healthcare providers involved in the care of pediatric patients with this condition. By recognizing these factors, clinicians can tailor treatment plans to optimize outcomes and provide appropriate support to patients and their families. It is essential to consider both clinical and biological factors when assessing prognosis in Hodgkin lymphoma to ensure the best possible care for patients.